Categories Uncategorized

What You Should Know About Chronic Rhinitis

Ever heard of chronic rhinitis? No? Well, it’s a condition that results in the inflammation of the inner lining of your nose. It can last for more than a month, and statistics show that 77 million individuals in America have the disease. Chronic rhinitis is not acute rhinitis, which only lasts several days.

There are two types of chronic rhinitis: the non-allergic and allergic types. An estimated 19 million individuals in America suffer from the less common non-allergic type while the remaining 58 million have the allergic type, making the latter very common. We discuss both types below.

Non-allergic chronic rhinitis

This type occurs mostly due to various triggers that exist in the environment. Its symptoms present differently in different people and are present year round. Some of these triggers are found in medications, other come from diseases and the environment. These triggers may be mechanical.

There are some medication classifications that are known to cause non-allergic chronic rhinitis. These include birth control pills, NSAIDs such as aspirin, antidepressants, illegal drugs such as cocaine and decongestant drugs that are used for more than three days.

Irritants in the environment

These include latex, detergents, metal salts, exhaust fumes from cars, perfume and tobacco smoke.

Ailments

Chronic sinusitis, gastroesophageal reflux disease and asthma can lead to non-allergic rhinitis.

Apart from the above triggers, extremely hot and spicy foods as well as hormonal changes can also cause non-allergic rhinitis.

Allergic chronic rhinitis

This usually occurs when an individual is exposed to an allergen; it  is also often referred to as hay fever. Its causes may include mold, pollen, animal dander, dust and cold.

Both types of chronic rhinitis share the following symptoms:

  • Coughing
  • Frequent sneezing
  • Post-nasal drip
  • Congestion of the nose
  • A running nose
  • Headaches

Chronic rhinitis can be treated in several ways. It should be noted that treatment is the most effective when combined with a lifestyle change. Possible treatments include:

Surgery

If a deviated septum is the cause of your chronic rhinitis, your doctor may recommend surgery. Despite being effective, it is used as a last resort after all other treatment options have been unsuccessful.

Changing your lifestyle

This is mainly done by avoiding anything that may trigger your rhinitis. You can incorporate an air purifier into your home, bathe your pets more often and dust your house frequently.

Medication

Possible medications include antihistamines, which essentially stop the development of rhinitis symptoms such as sneezing and a runny nose. Doctors may also prescribe nasal decongestants, which usually come in form of nasal drops to help alleviate nasal congestion.

Many biomedical firms are hard at work finding solutions to some of the most difficult conditions that people grapple with. For instance, Processa Pharmaceuticals Inc. (NASDAQ: PCSA) specializes in developing drugs for orphan diseases as well as other unmet medical needs.

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

The Global Market for Brain Tumor Treatments Will Reach $7.15 Billion by 2035

The global market for brain tumor treatments is experiencing significant transformation powered by advances in…

2 days ago

New Blood Test Shows Potential in Revolutionizing Early Parkinson’s Detection

A team of researchers has developed a “cost-effective” and simple blood test with the potential…

4 days ago

Nutriband Inc. (NASDAQ: NTRB) Is ‘One to Watch’

Nutriband’s AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible…

4 days ago

Nutriband Inc. (NASDAQ: NTRB) Leading the Way in Transformative Partnerships Formed in Growing Pharma Sector

Strategic partnerships embrace opportunities to foster innovation, streamline processes and ultimately improve the lives of…

5 days ago

Adageis Helps Medical Providers Track and Build Revenue Through Efficient Application of Value-Based Care

Adageis provides clinics and medical groups with AI-powered tools to track financial outcomes tied to…

1 week ago

Blocking an Enzyme in Melanoma Patients Could Overcome Resistance to Immunotherapy

Approximately 65% of patients diagnosed with melanoma are unresponsive to immunotherapy. New research suggests that…

1 week ago